Erosive oral lichen planus successfully treated with JAK3/TEC inhibitor ritlecitinib: A case report
- PMID: 40787044
- PMCID: PMC12329467
- DOI: 10.1016/j.jdcr.2025.05.017
Erosive oral lichen planus successfully treated with JAK3/TEC inhibitor ritlecitinib: A case report
Keywords: Janus kinase 3 inhibition; bullous skin diseases; erosive oral lichen planus; ritlecitinib.
Conflict of interest statement
None disclosed.
Figures
References
-
- Ginat W., Mirowski, Culton D.A. UpToDate; 2023. Oral lichen planus: pathogenesis, clinical features, and diagnosis.https://www.uptodate.com/contents/oral-lichen-planus-pathogenesis-clinic...
Publication types
LinkOut - more resources
Full Text Sources